Milestone Pharmaceuticals Inc. (NASDAQ:MIST) shares hit a new 52-week high during trading on Wednesday after an insider bought additional shares in the company. The stock traded as high as $19.09 and last traded at $18.38, with a volume of 3298 shares changing hands. The stock had previously closed at $18.55.
Specifically, major shareholder Rtw Investments, Lp purchased 666,667 shares of Milestone Pharmaceuticals stock in a transaction dated Thursday, May 9th. The shares were purchased at an average price of $15.00 per share, with a total value of $10,000,005.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, major shareholder Holdings A/S Novo purchased 333,333 shares of Milestone Pharmaceuticals stock in a transaction dated Monday, May 13th. The shares were purchased at an average cost of $15.00 per share, for a total transaction of $4,999,995.00. The disclosure for this purchase can be found here.
About Milestone Pharmaceuticals (NASDAQ:MIST)
Milestone Pharmaceuticals Inc, a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina.
Featured Article: Overbought
Receive News & Ratings for Milestone Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.